FIRST QUADRANT LLC/CA - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 231 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
FIRST QUADRANT LLC/CA ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$262,000
-9.7%
16,9000.0%0.02%
+25.0%
Q2 2019$290,000
+6.6%
16,9000.0%0.02%
-4.8%
Q1 2019$272,000
-55.4%
16,900
-59.5%
0.02%
-57.1%
Q4 2018$610,000
-36.7%
41,687
-21.4%
0.05%
+133.3%
Q3 2018$964,000
-43.4%
53,031
-47.5%
0.02%
-34.4%
Q2 2018$1,703,000
+252.6%
100,933
+309.3%
0.03%
+255.6%
Q1 2018$483,000
+403.1%
24,662
+418.4%
0.01%
+350.0%
Q4 2017$96,0004,7570.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
TRAN CAPITAL MANAGEMENT, L.P. 1,506,473$61,283,0005.13%
First Light Asset Management, LLC 1,477,496$60,105,0003.96%
SNYDER CAPITAL MANAGEMENT L P 3,427,476$139,430,0003.69%
DOHENY ASSET MANAGEMENT /CA 80,400$3,271,0002.34%
Redwood Investments, LLC 619,766$25,212,0002.11%
HighMark Wealth Management LLC 53,341$2,170,0001.60%
SILVERARC CAPITAL MANAGEMENT, LLC 60,170$2,448,0001.38%
Third Security, LLC 168,604$6,859,0001.33%
Taylor Wealth Management Partners 87,654$3,566,0001.27%
Penn Capital Management Company, LLC 290,394$11,813,0001.19%
View complete list of HALOZYME THERAPEUTICS INC shareholders